The relative significance of human placental lactogen in the diagnosis of retarded fetal growth. 1979

N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King

The purpose of this prospective study was to determine whether serial maternal venous hPL determinations could identify pregnancies resulting in growth-retarded infants from a selected population at presumed high risk for IUGR. Our results demonstrated that mean hPL levels in IUGR outcome pregnancies were significantly lower than normal after 33 weeks' gestation. Mean hPL was also lower in some pregnancies resulting in normal-weight neonates with abnormally low PI or short CHL, suggesting that these neonates, despite normal birth weight achievement, may represent previously unsuspected.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010928 Placental Lactogen A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist. Choriomammotropin,Chorionic Somatomammotropin, Human,Human Placental Lactogen,Lactogen Hormone, Placental,Mammotropic Hormone, Placental,Somatomammotropin, Chorionic,Choriomammotrophin,HCS (Human Chorionic Somatomammotropin),HPL (Human Placental Lactogen),PAPP-D,Placental Luteotropin,Pregnancy-Associated Plasma Protein D,Chorionic Somatomammotropin,Human Chorionic Somatomammotropin,Lactogen, Placental,Luteotropin, Placental,Placental Lactogen, Human,Placental Mammotropic Hormone,Pregnancy Associated Plasma Protein D
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D001724 Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms. Birthweight,Birth Weights,Birthweights,Weight, Birth,Weights, Birth
D002508 Cephalometry The measurement of the dimensions of the HEAD. Craniometry
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction

Related Publications

N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
June 1988, The Journal of clinical endocrinology and metabolism,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
January 1988, Reproduction, nutrition, developpement,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
April 1980, Srpski arhiv za celokupno lekarstvo,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
January 1988, Akusherstvo i ginekologiia,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
December 1988, Pediatric research,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
September 1974, Lancet (London, England),
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
November 1975, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
April 2000, Journal of pediatric endocrinology & metabolism : JPEM,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
May 1986, American journal of obstetrics and gynecology,
N H Daikoku, and J E Tyson, and C Graf, and R Scott, and B Smith, and J W Johnson, and T M King
January 1974, Lancet (London, England),
Copied contents to your clipboard!